The shape of gene expression distributions matter: how incorporating distribution shape improves the interpretation of cancer transcriptomic data
暂无分享,去创建一个
[1] Jessica C. Mar,et al. Investigating skewness to understand gene expression heterogeneity in large patient cohorts , 2019, BMC Bioinformatics.
[2] Mahdi Sarmady,et al. A comparison of survival analysis methods for cancer gene expression RNA-Sequencing data. , 2019, Cancer genetics.
[3] Jessica C. Mar,et al. A novel approach to modelling transcriptional heterogeneity identifies the oncogene candidate CBX2 in invasive breast carcinoma , 2019, British Journal of Cancer.
[4] Hannes P. Eggertsson,et al. Characterizing mutagenic effects of recombination through a sequence-level genetic map , 2019, Science.
[5] Jessica C Mar,et al. The rise of the distributions: why non-normality is important for understanding the transcriptome and beyond , 2019, Biophysical Reviews.
[6] R. Gregory,et al. MicroRNA biogenesis pathways in cancer , 2015, Nature Reviews Cancer.
[7] Amit Verma,et al. HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia. , 2014, The Journal of clinical investigation.
[8] Songnian Hu,et al. Dynamic transcriptomes of human myeloid leukemia cells. , 2013, Genomics.
[9] Benjamin J. Raphael,et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.
[10] Ulrich Mansmann,et al. Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Hany Ariffin,et al. Mature B‐cell acute lymphoblastic leukaemia associated with a rare MLL‐FOXO4 fusion gene , 2012, British journal of haematology.
[12] M. Datto,et al. Genes with bimodal expression are robust diagnostic targets that define distinct subtypes of epithelial ovarian cancer with different overall survival. , 2012, The Journal of molecular diagnostics : JMD.
[13] Ben Davidson,et al. Epithelial–Mesenchymal Transition in Ovarian Carcinoma , 2012, Front. Oncol..
[14] Angelo J. Canty,et al. Stem cell gene expression programs influence clinical outcome in human leukemia , 2011, Nature Medicine.
[15] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[16] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[17] Guido Marcucci,et al. The prognostic and functional role of microRNAs in acute myeloid leukemia. , 2011, Blood.
[18] Ash A. Alizadeh,et al. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. , 2010, JAMA.
[19] Kevin R. Coombes,et al. The Bimodality Index: A Criterion for Discovering and Ranking Bimodal Signatures from Cancer Gene Expression Profiling Data , 2009, Cancer informatics.
[20] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[21] Hemant Ishwaran,et al. Random Survival Forests , 2008, Wiley StatsRef: Statistics Reference Online.
[22] Adam Ertel,et al. Switch-like genes populate cell communication pathways and are enriched for extracellular proteins , 2008, BMC Genomics.
[23] R. Verhaak,et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. , 2004, The New England journal of medicine.
[24] Chi Wai So,et al. Common mechanism for oncogenic activation of MLL by forkhead family proteins. , 2003, Blood.
[25] H. Lilliefors. On the Kolmogorov-Smirnov Test for Normality with Mean and Variance Unknown , 1967 .
[26] S. Shapiro,et al. An Analysis of Variance Test for Normality (Complete Samples) , 1965 .
[27] N. Smirnov. Table for Estimating the Goodness of Fit of Empirical Distributions , 1948 .
[28] Kevin R Coombes,et al. Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation. , 2012, European journal of cancer.
[29] S. Shapiro,et al. An analysis of variance test for normality ( complete samp 1 es ) t , 2007 .
[30] Christina Kendziorski,et al. On Differential Variability of Expression Ratios: Improving Statistical Inference about Gene Expression Changes from Microarray Data , 2001, J. Comput. Biol..